Elizabeth Tree-Levasseur
Family Medicine · Whitehall, MINPI 1194716878
Payments from drug & device makers
Across 292 payments — averaging $12.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$527
- GSK$418
- AstraZeneca$359
- Pfizer$313
- Boehringer Ingelheim$265
- Lilly USA, LLC$254
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,47097%
- Education$1043%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 58 | $527 |
| GSK | 49 | $418 |
| AstraZeneca | 12 | $359 |
| Pfizer | 38 | $313 |
| Boehringer Ingelheim | 15 | $265 |
| Lilly USA, LLC | 30 | $254 |
| Novartis | 10 | $178 |
| Merck | 13 | $172 |
| Astellas Pharma US Inc | 5 | $155 |
| AbbVie(2 entities) | 10 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $151 |
| Amgen | 7 | $121 |
| Mylan Specialty L.p. | 5 | $69 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Teva Pharmaceuticals USA, Inc. | 4 | $49 |
| E.r. Squibb & Sons, L.L.C. | 4 | $47 |
| Amarin Pharma, Inc. | 3 | $46 |
| Supernus Pharmaceuticals, Inc. | 3 | $44 |
| UCB, Inc. | 2 | $36 |
| Genentech USA, Inc. | 2 | $26 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Eisai Inc. | 1 | $25 |
| Johnson & Johnson | 2 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Circassia Inc. | 1 | $13 |
| Bayer | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$120
- SYMBICORT$120
- BYDUREON$120
- BEVESPI AEROSPHERE$120
How this compares
$3,573 in reported general payments places this provider in the 85th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 200 | $186,810 |
| EliquisApixaban | 131 | $128,950 |
| TrulicityDulaglutide | 79 | $93,775 |
| OzempicSemaglutide | 77 | $90,890 |
| MounjaroTirzepatide | 80 | $85,236 |
| XareltoRivaroxaban | 37 | $44,178 |
| MyrbetriqMirabegron | 41 | $33,191 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $26,808 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $25,603 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 35 | $25,274 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $24,063 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $21,091 |
| VraylarCariprazine Hcl | 15 | $20,185 |
| Bydureon BciseExenatide Microspheres | 21 | $18,853 |
| RexultiBrexpiprazole | 11 | $15,565 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Stiolto Respimat, Spiriva Respimat | $265 | $221,138247 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $254 | $179,011159 claims |
| PfizerEliquis | $313 | $128,950131 claims |
| Novo NordiskOzempic | $527 | $90,89077 claims |
| Johnson & JohnsonXarelto | $24 | $44,17837 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $418 | $38,83655 claims |
| AbbVieVraylar, Linzess, Synthroid | $151 | $38,102116 claims |
| Astellas Pharma US IncMyrbetriq | $155 | $33,19141 claims |
| AstraZenecaFarxiga, Symbicort | $359 | $25,09139 claims |
| MerckJanuvia, Verquvo | $172 | $22,55737 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $66 | $15,56511 claims |
| NovartisEntresto | $178 | $14,32422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Whitehall
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
- Rhonda MejeurGrand Rapids$493K
- Steve LasaterSaint Johns$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.